Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Rubicon Organics Q2 revenue rises on yield gains at Pacifica facility

Rubicon Organics Q2 revenue rises on yield gains at Pacifica facility

ReutersReuters2026/08/12 11:17


Overview

  • Canada premium cannabis producer's Q2 net revenue grew 23% yr/yr, driven by facility yield gains

  • Adjusted EBITDA for Q2 fell 18% yr/yr, reflecting investments to scale production

  • Company maintained #1 premium licensed producer position in Canada with increased market share


Outlook

  • Company expects net revenue and Adjusted EBITDA to ramp up in H2 2026

  • Rubicon expects Cascadia facility yields to reach target by end of 2026

  • Company anticipates margin benefits from 2026 projects to be fully realized by early 2027


Result Drivers

  • FACILITY YIELD GAINS - Co said revenue growth was driven by improved yields and efficiency at the Pacifica facility

  • CASCADIA RAMP-UP - Initial revenues from the Cascadia facility contributed to Q2 results as production came online

  • INVESTMENTS IMPACT EBITDA - Adjusted EBITDA declined due to investments to scale the business and ramp up Cascadia


Company press release: ID:nGNX3BmVVd


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

C$18.50 mln

C$16.60 mln (2 Analysts)

Q2 Adjusted EBITDA

C$1.10 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Rubicon Organics Inc is C$1.15, about 130% above its August 11 closing price of C$0.50

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 7 three months ago


Reuters Recommended Reads

  • Aug 10 - Canadian cannabis producer Village Farms beats 'Q2 sales, EPS estimates on record yields, exports

  • Aug 11 - Canada's Organigram Q3 revenue beats on Sanity acquisition; CFO to exit

  • Aug 11 - Vireo Growth Q2 revenue jumps on acquisitions


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!